Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Oesophagogastric Cancer × Neoadjuvant Therapy × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 42 Rectal Neoplasms 41 Esophageal Neoplasms 22 Esophageal Squamous Cell Carcinoma 20 Stomach Neoplasms 17 Pancreatic Neoplasms 17 Colonic Neoplasms 13 Carcinoma, Hepatocellular 13 Adenocarcinoma Of Esophagus 11 Neoplasm Metastasis 7 Liver Neoplasms 6 Recurrence 4 Locally Advanced Rectal Cancer 4 Cholangiocarcinoma 4 Turcot syndrome 3 Peritoneal Neoplasms 2 Neoplasms 2 Gastrointestinal Stromal Tumors 2 Adenocarcinoma 2 Surgery 1 Successful Conversion Rate of Operation 1 Radiation Injuries 1 QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy 1 Peritoneal Metastases From Gastric Cancer 1 Peritoneal Metastases From Colorectal Cancer 1 Pathologic Complete Response 1 Pancreatic Ductal Adenocarcinoma 1 Oesophagogastric Cancer 1 Neoplastic Cells, Circulating 1 Neoplasms, Squamous Cell 1

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡